Complement receptor is an inhibitor of the complement cascade.
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
A glycoprotein from the membrane of human erythrocytes has been identified as a receptor for C3b (CR1). It promotes the dissociation of the alternative pathway C3 convertase C3b,Bb and the cleavage of C3b by C3b/C4b inactivator. We find that CR1 also inactivates the C3 and C5 convertases of the classical pathway. CR1 inhibits the consumption of C3 by C3 convertase EAC142 and enhances the decay of C4b,2a sites. On a weight basis, CR1 is approximately 5-10 times more active than C4 binding protein, a serum inhibitor of C4b,2a. The binding of 125I-CR1 to EAC14 cells is inhibited by C2. Therefore, it is likely that CR1 and C2 compete for a site on C4b. CR1 inhibited C5 convertase even more effectively, but had no effect on the assembly of the late complement components. At high concentrations, CR1 alone has no irreversible effects on cell-bound C4b. In the fluid phase, CR1 can function as a cofactor for the cleavage of the alpha' chain of C4b by C3b/C4b inactivator. A well-known function of CR1 is to promote adherence of microbes or immune complexes bearing C3b and C4b to cells. This interaction could result in a microenvironment damaging to the plasma membrane of the responding cell because the extrinsic C3b and C4b fragments can serve as additional sites of assembly of enzymes of the cascade. We therefore wish to propose that CR1 on the surface of cells supplies an increased local concentration of a strong inhibitor of the amplifying enzymes of the complement system and provides cells with a mechanism for circumventing damage when they bind C3b- and C4b-bearing substrates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.1.257 · Cited by 684
RECEPTORS FOR COMPLEMENT ON LEUKOCYTES
Lay, W. H., & Nussenzweig, V. (1968) · The Journal of Experimental Medicine · doi:10.1084/jem.128.5.991 · Cited by 672
Self-citationFearon, D. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.1.20 · Cited by 644
Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler, J. M., Daha, M. R., Austen, K. F., & Fearon, D. T. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3268 · Cited by 570
The role of membrane receptors for C3b and C3d in phagocytosis.
Ehlenberger, A. G., & Nussenzweig, V (1977) · The Journal of experimental medicine · doi:10.1084/jem.145.2.357 · Cited by 534
Self-citationThird component of human complement: purification from plasma and physicochemical characterization
Tack, B. F., & Prahl, J. W. (1976) · Biochemistry · doi:10.1021/bi00665a028 · Cited by 516
Nelson, R. A. (1953) · Science · doi:10.1126/science.118.3077.733 · Cited by 493
Huber, H. P., Polley, M. J., Linscott, W. D., Fudenberg, H. H., & Müller‐Eberhard, H. J. (1968) · Science · doi:10.1126/science.162.3859.1281 · Cited by 486
Cited by
Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., & Fearon, D. T. (1990) · Science · doi:10.1126/science.2371562 · Cited by 977
The impact of sex on gene expression across human tissues
Oliva, M., Muñoz-Aguirre, M., Kim-Hellmuth, S., Wucher, V., Gewirtz, A. D. H., Cotter, D. J., Parsana, P., Kasela, S., Balliu, B., Viñuela, A., et al. (2020) · Science · doi:10.1126/science.aba3066 · Cited by 670
Medof, M. E., Kinoshita, T., & Nussenzweig, V (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1558 · Cited by 561
Self-citationPrimate erythrocyte-immune complex-clearing mechanism.
Cornacoff, J. B., Hebert, L. A., Smead, W. L., VanAman, M. E., Birmingham, D. J., & Waxman, F. J. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110764 · Cited by 489
Structure and Function of the Complement Receptors, CR1 (CD35) and CR2 (CD21)
Ahearn, J. M., & Fearon, D. T. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60654-9 · Cited by 448
The Regulators of Complement Activation (RCA) Gene Cluster
Hourcade, D., Holers, V. M., & Atkinson, J. P. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60697-5 · Cited by 439
Wright, S. D., & Silverstein, S. C. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.4.1149 · Cited by 435
Seya, T., Turner, J. R., & Atkinson, J. P. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.4.837 · Cited by 398
Friedman, H. M., Cohen, G. H., Eisenberg, R. J., Seidel, C. A., & Cines, D. B. (1984) · Nature · doi:10.1038/309633a0 · Cited by 383
Iida, K., Mornaghi, R., & Nussenzweig, V (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1427 · Cited by 339
Self-citationMedof, M. E., Iida, K., Mold, C., & Nussenzweig, V (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.6.1739 · Cited by 334
Self-citationPangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5430 · Cited by 317
Membrane Complement Receptors Specific for Bound Fragments of C3
Ross, G. D., & Medof, M. E. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60341-7 · Cited by 308
Erythrocyte‐Inspired Delivery Systems
Hu, C. J., Fang, R. H., & Zhang, L. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200138 · Cited by 308
The alternative pathway of complement
Pangburn, M. K., & Müller-Eberhard, H. J. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893019 · Cited by 291
Complement-mediated regulation of tissue factor activity in endothelium.
Saadi, S., Holzknecht, R. A., Patte, C. P., Stern, D. M., & Platt, J. L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1807 · Cited by 290
Complement Ligand-Receptor Interactions that Mediate Biological Responses
Fearon, D. T., & Wong, W. W. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001331 · Cited by 290
Klickstein, L. B., Wong, W. W., Smith, J. A., Weis, J. H., Wilson, J. G., & Fearon, D. T. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.4.1095 · Cited by 261
Complement receptors and their role in leukocyte recruitment and phagocytosis
Vandendriessche, S., Cambier, S., Proost, P., & Marques, P. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.624025 · Cited by 178
“This promotes factor I-mediated degradation of C3b and C4b, and the cleavage of iC3b to C3c and C3dg (Iida and Nussenzweig, 1981; Masaki et al., 1992).”
Background
Metadata
- Authors
- Iida, K., & Nussenzweig, V
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1981-05-01
- Volume
- 153
- Issue
- 5
- Pages
- 1138-1150
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2048005561
- Cited by
- 264
- References
- 26
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.